Clinical Study

Quinolone Prophylaxis in Transrectal Ultrasound Guided Prostate Biopsy: An Eight-Year Single Center Experience

Table 2

The relationship between potential risk factors and febrile UTI rate assessed with multivariate logistic regression analysis.

Risk factor Febrile UTI
(%)
OR95% CIP
+

Greater PSA levela2.12.00.970.56–1.490.72
Greater ageb2.02.10.910.59–1.580.90
≥12 core biopsy2.11.90.610.25–1.480.27
Out-patient clinic1.92.10.930.38–2.320.88
Prostate cancer1.52.31.460.80–2.650.22
Chronic inflammation2.52.01.070.42–2.750.89
Levofloxacin prophylaxis1.03.73.742.26–6.20<0.001

Greater than median PSA level.
bGreater than median age.